A Study of the Effect of RG1662 on Metformin in Healthy Volunteers
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This single-center, non-randomized, open-label, two treatment, two period, fixed sequence
crossover study will investigate the effect of RG1662 treatment on the activity of key renal
transporters in healthy male and female participants using metformin. The effect of RG1662 on
other renal function parameters will also be explored.